about
Osteoclast fusion is based on heterogeneity between fusion partnersTime-lapse reveals that osteoclasts can move across the bone surface while resorbing.Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.Pit- and trench-forming osteoclasts: a distinction that mattersHuman topoisomerase I forms double cleavage complexes on natural DNA.Does collagen trigger the recruitment of osteoblasts into vacated bone resorption lacunae during bone remodeling?Osteoclast Fusion: Time-Lapse Reveals Involvement of CD47 and Syncytin-1 at Different Stages of Nuclearity.p53 stimulates human topoisomerase I activity by modulating its DNA binding.A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin KErratum: Pit- and trench-forming osteoclasts: a distinction that matters.Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma.The human topoisomerase I damage response plays a role in apoptosis.Steering the osteoclast through the demineralization-collagenolysis balance.Coupling of Bone Resorption and Formation in Real Time: New Knowledge Gained From Human Haversian BMUs.Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled manner.The elementary fusion modalities of osteoclasts.Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion.Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycleSeptins are critical regulators of osteoclastic bone resorptionIs retention of zoledronic acid onto bone different in multiple myeloma and breast cancer patients with bone metastasis?Glucocorticoid-Induced Changes in the Geometry of Osteoclast Resorption Cavities Affect Trabecular Bone StiffnessPremature loss of bone remodeling compartment canopies is associated with deficient bone formation: A study of healthy individuals and patients with cushing's syndromeThe tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitroA Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in CultureCoordination of Fusion and Trafficking of Pre-osteoclasts at the Marrow-Bone InterfaceCatabolic activity of osteoblast lineage cells contributes to osteoclastic bone resorption in vitro
P50
Q33723296-B1CDC992-F4DE-4040-84AB-5F05E72B684BQ33830438-2EAE5DB9-9C81-43B2-8CB6-AFFFC7C51127Q34242787-791DB721-7BA3-4060-AD46-9A6E7037A08FQ34397019-0CE2CC6F-7E97-4E13-8211-4A0830C2628CQ36333959-936D9859-BA2D-4762-8623-5EDC3C3037F8Q38310353-74378A87-FA73-4627-B836-D287686E198AQ38975615-07C6F283-E10A-4945-8743-764D49B73F24Q39313615-AE9D0D2A-69E7-4AB6-86EC-1FCE92EFF3A2Q40240820-EA01BB87-30BF-49A6-8B17-F433A1000619Q41771681-7A1E5AA1-92FD-4088-B6EB-99B8450AF56AQ42387986-A09A0F2B-6BEC-4D33-8CA2-CBA9CC39858DQ43989561-F4476C91-B0D6-4347-927D-4B6421BDC98FQ44925729-DCCE7674-A8B7-4AC6-97AB-F28CD2E9D8A3Q47977431-880FA8F5-F926-497F-80DC-FCF4FB6A6F9AQ50897234-82238FA6-43C2-48EF-B515-CDDE2B4B0542Q50905010-70425217-9A78-46B2-8539-74345677B8D5Q52596937-1947C849-57E6-4D30-A574-508B83AEBF24Q52761114-7963597C-B919-49F8-AEA1-E1EE2076609FQ53615595-D5539E9F-641A-46A5-8DA3-27403259C811Q53657000-066DA7F3-0488-43E9-ABD8-75E09F0C5A72Q54400103-C0B99FFD-3B4D-4E69-850A-3A0012509E82Q57099557-646A1173-DCB9-405C-B34F-4FBF3B1B37DBQ57566198-4E135EFF-013B-4F7E-9959-876BEFE0B5F0Q57566233-E10CF12C-84F1-4673-9E2F-BC9DFA59A6A7Q57566235-1E6CDF8A-C34F-44AB-B869-CEA3F366D84AQ57566244-A26B4909-0FDB-4268-B2C5-25562056F39EQ57566282-7FA278D5-753D-452B-B704-18445A3A0ECFQ91336552-633C3103-7243-4252-9AA9-CDBF224933D1Q93005366-CBA72480-4DAD-4846-BBCB-C7FF7B219124Q93040711-859EF9F3-34CD-4562-8E28-38DBC18F2A12
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kent Soe
@ast
Kent Soe
@en
Kent Soe
@es
Kent Soe
@nl
Kent Soe
@sl
type
label
Kent Soe
@ast
Kent Soe
@en
Kent Soe
@es
Kent Soe
@nl
Kent Soe
@sl
prefLabel
Kent Soe
@ast
Kent Soe
@en
Kent Soe
@es
Kent Soe
@nl
Kent Soe
@sl
P108
P1053
N-3618-2017
P106
P1153
6602096758
P21
P2798
P31
P3829
P3835
P496
0000-0001-7402-314X